Zaneka Pharmaceuticals Private Limited, a active private limited company, was established on 26 May 1999 in Haridwar, Uttarakhand, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231UR1999PTC001430. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 27 professional, Its leadership includes Shifali (Director), Satish Chand Virmani (Director), Amit Virmani (Director). Past directors included Harish Chand Virmani, Manju Virmani, Ashu Virmani. It holds ₹9.00 M open charges and ₹2.20 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 120, Dwarika Vihar, Salempur Mehdood Bahadrabad, Haridwar, Uttarakhand, 249402.
U24231UR1999PTC001430
001430
26 May 1999
₹1.00 Cr
₹1.00 Cr
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Zaneka Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shifali | Director | 30 Jun 2011 | Current |
| Satish Chand Virmani | Director | 30 Jun 2011 | Current |
| Amit Virmani | Director | 30 Jun 2011 | Current |
| Shantanu Virmani | Director | 30 Jun 2011 | Current |
| Ashu Virmani | Director | 20 Jul 2022 | Current |
| Ashish Virmani | Director | 26 May 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 20 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 01 Mar 2011 | Past |
| Pramod Abcsdd | Director | 21 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zaneka Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.65% increase. The company also saw a substantial improvement in profitability, with a 296.95% increase in profit. The company's net worth moved up by a moderate rise of 5.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Zaneka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹9,000,000.00
₹2,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Feb 2021 | Axis Bank Limited | ₹5.00 M | Open |
| 27 Jan 2015 | Oriental Bank Of Commerce | ₹4.00 M | Open |
| 23 Jan 2008 | State Bank Of India | ₹2.00 M | Satisfied |
| 05 Feb 2003 | State Bank Of India | ₹0.20 M | Satisfied |
Explore comprehensive loan charge details -
Zaneka Pharmaceuticals has a workforce of 27 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zaneka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zaneka Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Zaneka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Zaneka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was recorded as a recent event.
Ashu Virmani was appointed as a Director was appointed as a Director on 20 Jul 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100428225 was registered on 05 Feb 2021. was recorded as a recent event.
Indu Batra was appointed as a Director was appointed as a Director on 21 Mar 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.
The activity A charge registered on 23 Jan 2008 via Charge ID 10090955 with State Bank Of India was fully satisfied on 23 Feb 2015. was completed.
The CIN of Zaneka Pharmaceuticals Private Limited is U24231UR1999PTC001430.
Zaneka Pharmaceuticals Private Limited is headquartered at 120, Dwarika Vihar, Salempur Mehdood Bahadrabad, Haridwar, Uttarakhand, 249402.
Zaneka Pharmaceuticals Private Limited was incorporated on 26 May 1999.
The current directors of Zaneka Pharmaceuticals Private Limited are
The primary industry of Zaneka Pharmaceuticals Private Limited is Trade.
Zaneka Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zaneka Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Zaneka Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX